S100A9 and neoplasm: Immunostaining was also used to validate microarray analysis and found increased expression of S100A9 and REG1α in CA-CRC and in non-dysplastic tissue from patients with UC harbouring remote neoplasia, compared to patients with UC and without neoplasia and controls [181].